Medicare Enrolled
Dr. Sumit Sawhney, M.D.
Hematology & Oncology · Coral Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sawhney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sawhney? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sawhney
Dr. Sumit Sawhney is a hematology & oncology in Coral Springs, FL, with 20 years in practice. Based on federal Medicare data, Dr. Sawhney performed 23,632 Medicare services across 1,876 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sawhney received a total of $128,784 from 95 pharmaceutical and/or device companies across 1553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sawhney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 22% volume in FL$ $128,784 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,632
Medicare services
Top 22% in FL for hematology & oncology
1,876
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,182 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Retacrit) for anemia | 3,820 | $6 | $20 |
| Epoetin alfa injection (Procrit) for anemia | 3,540 | $6 | $21 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $17 | $54 |
| Anti-nausea injection (ondansetron/Zofran) | 2,392 | $0 | $3 |
| Iron infusion (Monoferric) | 2,300 | $17 | $60 |
| Dexamethasone injection (steroid) | 1,633 | $0 | $0 |
| Blood draw (venipuncture) | 1,300 | $7 | $8 |
| Complete blood count (CBC) with differential | 1,270 | $8 | $19 |
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 840 | $2 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 711 | $1 | $2 |
| Office visit, established patient (20-29 min) | 669 | $66 | $229 |
| Administration of chemotherapy into vein, 1 hour or less | 333 | $105 | $331 |
| Drug injection, under skin or into muscle | 308 | $11 | $35 |
| Injection of additional new drug or substance into vein | 280 | $12 | $39 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 231 | $22 | $29 |
| Administration of chemotherapy into vein, each additional hour | 202 | $23 | $72 |
| Ferritin level test (iron stores) | 185 | $13 | $78 |
| Injection, diphenhydramine hcl, up to 50 mg | 147 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 118 | $50 | $161 |
| Carcinoembryonic antigen (cea) protein level | 109 | $19 | $47 |
| Hospital follow-up visit, high complexity | 108 | $96 | $304 |
| Office visit, established patient (30-39 min) | 90 | $101 | $324 |
| Initial hospital admission, high complexity | 71 | $142 | $442 |
| Administration of additional new drug or substance into vein, 1 hour or less | 68 | $51 | $64 |
| Vitamin B-12 level test | 58 | $15 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 48 | $20 | $60 |
| New patient office visit (45-59 min) | 47 | $121 | $175 |
| Administration of additional new drug or substance into vein using push technique | 42 | $45 | $141 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 41 | $15 | $20 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 37 | $1 | $4 |
| PSA test (prostate cancer screening) | 33 | $18 | $46 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 21 | $14 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.4% high complexity
71.3% medium
17.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$128,784
Total received (2018-2024)
Avg $18,398/year across 7 years
Top 8% in FL for hematology & oncology
95
Companies
1,553
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$94,524 (73.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,419 (15.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,841 (10.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$9,533
2023$9,674
2022$18,769
2021$20,753
2020$16,178
2019$20,014
2018$33,863
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$14,597
Bayer HealthCare Pharmaceuticals Inc.
$10,769
Celgene Corporation
$10,259
Janssen Scientific Affairs, LLC
$8,865
Janssen Biotech, Inc.
$7,617
GENZYME CORPORATION
$6,395
Pharmacosmos Therapeutics Inc.
$5,332
EISAI INC.
$4,995
SUN PHARMACEUTICAL INDUSTRIES INC.
$4,823
Takeda Pharmaceuticals U.S.A., Inc.
$4,475
Novocure Inc.
$4,192
JAZZ PHARMACEUTICALS INC.
$4,190
Athenex Pharmaceutical Division, LLC
$4,025
GlaxoSmithKline, LLC.
$3,886
Ipsen Biopharmaceuticals, Inc
$3,300
Amgen Inc.
$3,108
AbbVie, Inc.
$2,919
BeiGene USA, Inc.
$2,701
Rigel Pharmaceuticals, Inc.
$1,666
E.R. Squibb & Sons, L.L.C.
$1,603
PFIZER INC.
$1,595
Eagle Pharmaceuticals, Inc.
$1,510
TAIHO ONCOLOGY, INC.
$1,400
Puma Biotechnology, Inc.
$1,208
Exelixis Inc.
$1,067
Lilly USA, LLC
$957
Novartis Pharmaceuticals Corporation
$842
Genentech USA, Inc.
$715
Daiichi Sankyo Inc.
$651
Incyte Corporation
$603
Merck Sharp & Dohme Corporation
$528
Seagen Inc.
$528
BeiGene, Ltd.
$525
Eisai Inc.
$517
Alexion Pharmaceuticals, Inc.
$426
Dr.Reddy's Laboratories,Inc.
$400
Foundation Medicine, Inc.
$398
Astellas Pharma US Inc
$305
COMSORT, Inc
$250
TerSera Therapeutics LLC
$248
AbbVie Inc.
$220
Gilead Sciences, Inc.
$208
Novocure GmbH
$200
Seattle Genetics, Inc.
$197
ABBVIE INC.
$194
TOLMAR Pharmaceuticals, Inc.
$174
Janssen Pharmaceuticals, Inc
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Karyopharm Therapeutics Inc.
$150
Dova Pharmaceuticals
$148
Deciphera Pharmaceuticals Inc.
$142
ARRAY BIOPHARMA INC
$137
PUMA BIOTECHNOLOGY, INC.
$126
Bayer Healthcare Pharmaceuticals Inc.
$125
Adaptive Biotechnologies Corporation
$114
EMD Serono, Inc.
$111
MEDIVATION FIELD SOLUTIONS LLC
$111
Merck Sharp & Dohme LLC
$108
IntrinsiQ Specialty Solutions, Inc.
$100
Cardinal Health 110 LLC
$100
Regeneron Healthcare Solutions, Inc.
$94
Teva Pharmaceuticals USA, Inc.
$85
Coherus Biosciences Inc.
$84
Pharmacyclics LLC, An AbbVie Company
$81
SERVIER PHARMACEUTICALS LLC
$70
Aurobindo Pharma USA, Inc.
$69
Clovis Oncology, Inc.
$69
Sobi, Inc
$69
Sun Pharmaceutical Industries Inc.
$65
Taiho Oncology, Inc.
$64
Verastem, Inc.
$56
Spectrum Pharmaceuticals Inc.
$51
Kyowa Kirin, Inc.
$51
Amneal Pharmaceuticals LLC
$43
Mirati Therapeutics, Inc.
$43
TESARO, Inc.
$39
Advanced Accelerator Applications
$31
Blue Earth Diagnostics Limited
$26
Octapharma USA, Inc.
$25
Kite Pharma, Inc.
$25
Shire North American Group Inc
$23
AVEO Pharmaceuticals, Inc.
$23
ImmunoGen, Inc.
$22
Tolmar, Inc.
$21
Organon LLC
$21
Verity Pharmaceuticals Inc.
$20
Acceleron Pharma, Inc.
$18
Heron Therapeutics, Inc.
$18
Ethicon US, LLC
$17
Myovant Sciences Inc.
$17
Stemline Therapeutics Inc.
$16
PORTOLA PHARMACEUTICALS, INC.
$15
Agios Pharmaceuticals, Inc.
$13
Array BioPharma Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 27.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · Alecensa · Aliqopa · Avastin · Axumin · BENDEKA · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Erleada · FARESTON · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAPLAS · OJJAARA · ONIVYDE · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Onivyde · Oral Paclitaxel · Orserdu · PADCEV · PEMAZYRE · PEMFEXY · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Pomalyst · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · WILATE · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · YONSA · YONSA (abiraterone acetate) · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYKADIA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in FL.
Equivalent to $545 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
115
Per 100K population
5.9
County median income
$74,534
Nearest hospital
BROWARD HEALTH CORAL SPRINGS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sawhney is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), and high industry engagement (consulting-driven, top 8%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sawhney experienced with epoetin alfa injection (retacrit) for anemia?
Based on Medicare claims data, Dr. Sawhney performed 3,820 epoetin alfa injection (retacrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sawhney receive payments from pharmaceutical companies?
Yes. Dr. Sawhney received a total of $128,784 from 95 companies across 1,553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sawhney's costs compare to other hematology & oncologys in Coral Springs?
Dr. Sawhney's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sawhney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Coral Springs
Browse hematology & oncologys in Coral Springs ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology